메뉴 건너뛰기




Volumn 38, Issue 9, 2006, Pages 2856-2859

Conversion to Enteric-Coated Mycophenolate Sodium From Various Doses of Mycophenolate Mofetil: Results of a Prospective International Multicenter Trial in Maintenance Renal Transplant Patients Receiving Cyclosporine

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

EID: 33750950096     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.118     Document Type: Article
Times cited : (17)

References (17)
  • 1
    • 0029115531 scopus 로고
    • US Renal Transplant Mycophenolate Mofetil Study Group: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
    • Sollinger H.W. US Renal Transplant Mycophenolate Mofetil Study Group: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60 (1995) 225
    • (1995) Transplantation , vol.60 , pp. 225
    • Sollinger, H.W.1
  • 2
    • 0006986048 scopus 로고    scopus 로고
    • A blinded, randomized, clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
    • The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group
    • The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized, clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61 (1996) 1029
    • (1996) Transplantation , vol.61 , pp. 1029
  • 3
    • 0034660104 scopus 로고    scopus 로고
    • Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection
    • Ojo A., Meier-Kriesche H.U., Hanson J.A., et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69 (2000) 2405
    • (2000) Transplantation , vol.69 , pp. 2405
    • Ojo, A.1    Meier-Kriesche, H.U.2    Hanson, J.A.3
  • 4
    • 0242417526 scopus 로고    scopus 로고
    • Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration
    • Meier-Kriesche H.U., Steffen B.J., Hochberg A.M., et al. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation 75 (2003) 1341
    • (2003) Transplantation , vol.75 , pp. 1341
    • Meier-Kriesche, H.U.1    Steffen, B.J.2    Hochberg, A.M.3
  • 5
    • 12144273473 scopus 로고    scopus 로고
    • Long-term outcomes of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil
    • Hardinger K.L., Brennan D.C., Lowell J., et al. Long-term outcomes of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transplant Int 17 (2004) 609
    • (2004) Transplant Int , vol.17 , pp. 609
    • Hardinger, K.L.1    Brennan, D.C.2    Lowell, J.3
  • 6
    • 0037663784 scopus 로고    scopus 로고
    • The impact of mycophenolate dosing patterns on clinical outcomes after renal transplantation
    • Pelletier R.P., Akin B., Henry M.L., et al. The impact of mycophenolate dosing patterns on clinical outcomes after renal transplantation. Clin Transplant 17 (2003) 200
    • (2003) Clin Transplant , vol.17 , pp. 200
    • Pelletier, R.P.1    Akin, B.2    Henry, M.L.3
  • 7
    • 0042536429 scopus 로고    scopus 로고
    • Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation
    • Knoll G.A., MacDonald I., Khan A., et al. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 14 (2003) 2381
    • (2003) J Am Soc Nephrol , vol.14 , pp. 2381
    • Knoll, G.A.1    MacDonald, I.2    Khan, A.3
  • 8
    • 33750953529 scopus 로고    scopus 로고
    • Consequences of immunosuppression minimization following diagnosis of gastrointestinal complications in renal transplant
    • Schnitzler M.A., Hardinger K.L., Burroughs T.E., et al. Consequences of immunosuppression minimization following diagnosis of gastrointestinal complications in renal transplant. Am J Transplant 5 Suppl 11 (2005) 242
    • (2005) Am J Transplant , vol.5 , Issue.SUPPL. 11 , pp. 242
    • Schnitzler, M.A.1    Hardinger, K.L.2    Burroughs, T.E.3
  • 9
    • 15844416494 scopus 로고    scopus 로고
    • Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil
    • Arns W., Breuer S., Choudhury S., et al. Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil. Clin Transplant 19 (2005) 199
    • (2005) Clin Transplant , vol.19 , pp. 199
    • Arns, W.1    Breuer, S.2    Choudhury, S.3
  • 10
    • 3042772994 scopus 로고    scopus 로고
    • Review of the immunosuppressant enteric-coated mycophenolate sodium
    • Budde K., Glander P., Diekmann F., et al. Review of the immunosuppressant enteric-coated mycophenolate sodium. Expert Opin Pharmacother 5 (2004) 1333
    • (2004) Expert Opin Pharmacother , vol.5 , pp. 1333
    • Budde, K.1    Glander, P.2    Diekmann, F.3
  • 11
    • 1342346699 scopus 로고    scopus 로고
    • Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients
    • ERL B301 Study Group
    • Salvadori M., Holzer H., de Mattos A., et al., ERL B301 Study Group. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 4 (2004) 231
    • (2004) Am J Transplant , vol.4 , pp. 231
    • Salvadori, M.1    Holzer, H.2    de Mattos, A.3
  • 12
    • 33747104149 scopus 로고    scopus 로고
    • Long-term administration of enteric-coated mycophenolate sodium (EC-MPS, myfortic®) is safe in kidney transplant patients
    • Salvadori M., Holzer H., Civati G., et al. Long-term administration of enteric-coated mycophenolate sodium (EC-MPS, myfortic®) is safe in kidney transplant patients. Clin Nephrol 66 (2006) 112
    • (2006) Clin Nephrol , vol.66 , pp. 112
    • Salvadori, M.1    Holzer, H.2    Civati, G.3
  • 13
    • 1342325540 scopus 로고    scopus 로고
    • Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study
    • ERL B302 Study Group
    • Budde K., Curtis J., Knoll G., et al., ERL B302 Study Group. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study. Am J Transplant 4 (2004) 237
    • (2004) Am J Transplant , vol.4 , pp. 237
    • Budde, K.1    Curtis, J.2    Knoll, G.3
  • 14
    • 33747119649 scopus 로고    scopus 로고
    • Long-term safety and efficacy after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic®)
    • Budde K., Knoll G., Curtis J., et al. Long-term safety and efficacy after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic®). Clin Nephrol 66 (2006) 103
    • (2006) Clin Nephrol , vol.66 , pp. 103
    • Budde, K.1    Knoll, G.2    Curtis, J.3
  • 15
    • 4444331622 scopus 로고    scopus 로고
    • Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: interim results of a multicenter Latin American study
    • Myproms Latam Study Group
    • Abbud-Filho M., Girón F., Hernández E., et al., Myproms Latam Study Group. Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: interim results of a multicenter Latin American study. Transplant Proc 36 (2004) 1647
    • (2004) Transplant Proc , vol.36 , pp. 1647
    • Abbud-Filho, M.1    Girón, F.2    Hernández, E.3
  • 16
    • 33744494308 scopus 로고    scopus 로고
    • Patient-reported gastrointestinal symptom burden and health-related quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium
    • Chan L.K., Mulgaonkar S., Walker S., et al. Patient-reported gastrointestinal symptom burden and health-related quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium. Transplantation 81 (2006) 1290
    • (2006) Transplantation , vol.81 , pp. 1290
    • Chan, L.K.1    Mulgaonkar, S.2    Walker, S.3
  • 17
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31
    • (1976) Nephron , vol.16 , pp. 31
    • Cockcroft, D.W.1    Gault, M.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.